Search This Blog

Monday, January 7, 2019

Diplomat Pharmacy sees FY18 GAAP EPS (8c)-0c, consensus 80c


Lowers FY18 revenue view to $5.5B-$5.6B from $5.5B-$5.7B, consensus $5.56B. 2018 adjusted EBITDA is now expected to be within the range of $167M-$170M, an increase of at least 64% based on the low end of the 2018 range vs. 2017. Prior view was $164M-$170M.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.